| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |